Author

H. Kitamura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:differential expression· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

T. Ogura· 2 shared A. Ohsaka· 1 shared A. Sakurada· 1 shared D. Matsumaru· 1 shared F. Katsuoka· 1 shared H. Anzawa· 1 shared H. Motohashi· 1 shared H. Sekine· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

T. Ogura

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach

S. Kozawa, K. Tejima, S. Takagi, M. Kuroda, M. Nogami-Itoh, H. Kitamura, T. Niwa, T. Ogura, Y. Natsume-Kitatani, T. N. Sato

This study identifies an inter-organ mechanism of idiopathic pulmonary fibrosis (IPF) using a generative computational approach, revealing a liver-lung crosstalk involving kininogen 1 and bradykinin receptor B1.

bioRxiv · Apr 18, 2023Pathology

Enhancer Remodeling Promotes Tumor-Initiating Activity in NRF2-Activated Non-Small Cell Lung Cancers

K. Okazaki, H. Anzawa, Z. Liu, N. Ota, H. Kitamura, Y. Onodera, M. M. Alam, D. Matsumaru, T. Suzuki, F. Katsuoka, S. Tadaka, I. Motoike, M. Watanabe, A. Sakurada, Y. Okada, , H. Motohashi

The paper identifies NRF2-CEBPB cooperativity in promoting tumor-initiating activity in NRF2-activated NSCLCs through enhancer remodeling and the NRF2-NOTCH3 regulatory axis.

bioRxiv · Apr 24, 2020Cancer Biology

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib

Y. Tabe, H. Kitamura, K. Tsuchiya, M. Yuri, T. Ai, S. Misawa, T. Horii, A. Ohsaka, S. Kimura

This paper develops a new in-house RQ-PCR method for detecting BCR-ABL1 transcripts in CML patients, showing higher sensitivity than commercial methods for monitoring minimal residual disease.

bioRxiv · Oct 29, 2018Cancer Biology

Pirfenidone attenuates lung fibrotic fibroblast-mediated fibrotic responses to transforming growth factor-β1

J. Jin, S. Togo, K. Kadoya, m. tulafu, Y. Namba, M. Moe Iwai, J. Watanabe, K. Nagahama, T. Okabe, M. Hidayat, Y. Kodama, H. Kitamura, T. Ogura, N. Kitamura, K. Ikeo, , K. Takahashi

This study shows pirfenidone reduces fibrotic responses in lung fibroblasts by inhibiting CTHRC1, suggesting it as a potential therapeutic target for lung fibrosis.

bioRxiv · Aug 27, 2018Cell Biology